NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,282,644 | +203.5% | 118,764 | +301.4% | 0.01% | +100.0% |
| Q2 2023 | $752,051 | -80.5% | 29,585 | -72.2% | 0.00% | -94.8% |
| Q1 2023 | $3,849,830 | +279.9% | 106,496 | +316.2% | 0.06% | +222.2% |
| Q4 2022 | $1,013,285 | +273.9% | 25,588 | +339.7% | 0.02% | +260.0% |
| Q3 2022 | $271,000 | -71.0% | 5,819 | -72.7% | 0.01% | -80.8% |
| Q2 2022 | $933,000 | +46.0% | 21,291 | +140.9% | 0.03% | +52.9% |
| Q1 2022 | $639,000 | -37.5% | 8,838 | -29.9% | 0.02% | -46.9% |
| Q4 2021 | $1,022,000 | +129.1% | 12,609 | +229.4% | 0.03% | +146.2% |
| Q3 2021 | $446,000 | +89.0% | 3,828 | +125.6% | 0.01% | -50.0% |
| Q3 2020 | $236,000 | -36.4% | 1,697 | -60.6% | 0.03% | +13.0% |
| Q3 2019 | $371,000 | -10.8% | 4,310 | -32.9% | 0.02% | -50.0% |
| Q2 2019 | $416,000 | +96.2% | 6,420 | +72.8% | 0.05% | -53.5% |
| Q3 2018 | $212,000 | – | 3,716 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,776,368 | $34,141,793 | 1.08% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $66,424,320 | 1.02% |
| Palo Alto Investors LP | 386,832 | $7,434,911 | 0.70% |
| Rock Springs Capital Management LP | 1,211,600 | $23,286,952 | 0.62% |
| ArrowMark Colorado Holdings LLC | 2,468,110 | $47,437,074 | 0.58% |
| TD Capital Management LLC | 84,648 | $1,626,935 | 0.20% |
| Venator Management LLC | 25,000 | $480,500 | 0.18% |
| DAFNA Capital Management LLC | 28,000 | $538,160 | 0.17% |
| FRED ALGER MANAGEMENT, LLC | 1,053,812 | $20,254,266 | 0.12% |
| Counterpoint Mutual Funds LLC | 6,844 | $131,542 | 0.11% |